Interactive discussions - GLP-1 receptor agonists and CV risk management in type 2 diabetes: a new treatment paradigm?
28 August 2017 (13:20 - 13:45)
Organised by:
About the speakers
Karolinska Institute, Stockholm (Sweden)
University of Toronto, Toronto (Canada)
Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
3 More presentations in this session
Professor L. Ryden (Stockholm, SE)
Access the full session
The Event
ESC Congress 2017
28 August 2017
13:20 CET
